Park Medi World Q1 FY27 Revenue Up 19% to ₹476 Crores

Revenue from Operations: ₹476 crores, representing 19% year-on-year growth
EBITDA (excluding other income): ₹126 crores, with 20% year-on-year growth
EBITDA Margin: 26.5% (improved from 26.3% in Q1 FY26)
PAT: ₹89 crores, with 35% year-on-year growth
PAT Margin: 18.6% (expanded by 220 basis points year-on-year)
PAT margin expansion was largely attributed to reduction in interest outgo following substantial repayment of term debt

IPD Volumes: 26,304 patients (16% year-on-year growth)
OPD Volumes: 223,446 patients (17% year-on-year growth)
ARPOB: ₹30,444 (increased 12% from ₹27,221 in Q1 FY26)
ALOS: 5.9 days (improved 8% from 6.4 days a year ago)
Network Occupancy: 56% (compared to 68% in Q1 FY26)
High-end Specialties Contribution: Approximately 62% of revenue (increase of 440 basis points year-on-year)
Payer Mix: 77% from government insurance schemes, 23% from self-pay, private insurance and TPA

Current Bed Capacity: 3,960 beds as of June 30, 2026 (up 32% year-on-year)
Rudrapur Acquisition: Acquired 100% of The Medicity Hospital, Rudrapur, Uttarakhand for approximately ₹177 crores (all-cash transaction)
330-bed NABH-accredited Multi-Super Speciality Hospital
Commissioned on August 2, 2026
Expected first-year revenue: ₹100 crores with EBITDA of ₹20-22 crores
Expected second-year revenue: ₹140 crores with EBITDA of ₹35-36 crores
Additional CAPEX required: ₹10-12 crores

Gurgaon Expansion: 100-bed extension at Palam Vihar facility under 'Park Platinum' brand
Will take consolidated Gurgaon capacity to 750 beds
Total CAPEX: ₹25 crores (₹25 lakhs per bed)

Zirakpur Acquisition: Definitive agreement to acquire Mehar Hospital, Zirakpur for approximately ₹107 crores
150-bed Multi-Super Speciality Hospital
Scheduled commissioning in November/December 2026
Expected first-year revenue: ₹70-75 crores with EBITDA margin of 25-26%

Narela Facility: 200-bed hospital acquired through insolvency process on track for commissioning

Calendar Year 2026: Adding 1,490 beds (46% increase over 2025 capacity of 3,250 beds)
FY27 Ending Capacity: 4,740 beds
FY28 Ending Capacity: 5,740 beds (adding 1,000 beds in FY28)
Total CAPEX Plan (FY27-FY28): ₹767 crores for 2,130 beds, maintaining CAPEX per bed at ₹36 lakhs
Funding: Through internal accruals and IPO proceeds without recourse to fresh debt

Term Debt (excluding lease liability): ₹25.6 crores (down from ₹28.2 crores as of March 31, 2026)
Fixed Deposits: ₹300 crores
Net Worth: ₹2,100 crores
Debtor Days Target: 125-130 days medium-term target

All operational hospitals continue to be NABH-accredited
Panchkula facility progressing through NABH accreditation process
Nine hospitals with NABL-accredited labs (up from eight)
Planning four additional hospitals to obtain NABL accreditation in current financial year

CGHS rate hike of 12-15% implemented in October 2025
Expected benefit of 7-7.5% flowing into FY27
Fuller impact expected from Q2 FY27 as revised rates percolate through allied central government agencies
Partial impact already visible in Q1 results

Revenue: ₹2,080 crores (24% growth)
EBITDA: ₹530 crores (25% growth)
PAT: ₹360 crores (32% growth)
ARPOB Growth: 10-12% band
EBITDA Margin: Expected to remain steady at 26-27%
Payer Mix Target: 70:30 (government insurance schemes vs cash/TPA) over next 12-18 months

Focus on ramping up newer assets (Agra and Panchkula) while advancing growth pipeline
Expansion strategy includes positioning in new locations with high-potential markets and cluster formation through densification
Doctor retention strategy includes being among best paymasters, treating doctors as partners, performance bonus system, and robust ESOP program
Attrition rate at consultant level described as lowest in industry
OPD strategy focuses on footfall generation rather than revenue, with many free/subsidized camps and consultations